![Novoeight® [Antihemophilic Factor (Recombinant)]](/content/dam/novonordisk/novoeightpro/global-images/logo-novoeight.png){kind=logo}
Refer to dosing tables below for additional guidance.
Novoeight® dosing guidelines.1
The required dosage can be determined using the following formula:
For complete dosing information please see the Prescribing Information.
Dosage and duration of treatment depend on the severity of the factor VIII deficiency on the location and extent of bleeding, and the patient’s clinical condition. Careful monitoring of replacement therapy is necessary in cases of major surgery or life-threatening bleeding episodes.
Each vial of Novoeight® contains the labeled amount of recombinant factor VIII in international units (IU). One IU of factor VIII activity corresponds to the quantity of factor VIII in one milliliter of normal human plasma. The calculation of the required dosage of factor VIII is based on the empirical finding that one IU of factor VIII per kg body weight raises the plasma factor VIII activity by two IU/dL. This relationship causes a factor of 0.5 to be present in the dose calculation formula shown above.
Base the dose and frequency of Novoeight® on the individual clinical response. Patients may vary in their pharmacokinetic and clinical responses.
Dosing guide.
Dosing for control and prevention of bleeding episodes.1
Type of Bleeding Episodes
Minor
Early hemarthrosis, minor muscle or oral bleeding
Factor VIII Level Required (IU/dL or % of normal): 20-40
Frequency of Doses (hours): 12-24
Duration of Therapy (days): At least 1 day until bleeding resolution is achieved
Moderate
Muscle bleeding, bleeding into the oral cavity or mild head trauma
Factor VIII Level Required (IU/dL or % of normal): 30-60
Frequency of Doses (hours): 12-24
Duration of Therapy (days): Until pain and acute disability are resolved (approximately 3-4 days)
Major
Life or limb threatening hemorrhage, Gastrointestinal bleeding, intracranial, intra-abdominal or intrathoracic bleeding, fractures
Factor VIII Level Required (IU/dL or % of normal): 60-100
Frequency of Doses (hours): 8-24
Duration of Therapy (days): Until resolution of bleed (approximately 7-10 days)
Dosing for perioperative management.1
Type of Surgery
Minor
Including tooth extraction
Factor VIII Level Required (IU/dL or % of normal): 30-60
Frequency of Doses (hours): 12
Duration of Therapy (days): At least 1 day until healing is achieved
Major
Intracranial, intra-abdominal or intrathoracic, or joint replacement surgery
Factor VIII Level Required (IU/dL or % of normal): 80-100 (pre-and postoperative)
Frequency of Doses (hours): 8-24
Duration of Therapy (days): Until adequate wound healing, then continue therapy for at least 7 days to maintain a factor VIII activity of 30% to 60% (IU/dL)
Dosing for Routine Prophylaxis.1
Patient Population
Adults and adolescents (≥ 12 years)
Factor VIII Dose Required (IU/kg): 20-50
Frequency of Doses: 3 times weekly; Factor VIII Dose Required (IU/kg): 20-40
Frequency of Doses: Every other day
Children (<12 years)
Factor VIII Dose Required (IU/kg): 25-60
Frequency of Doses: 3 times weekly; Factor VIII Dose Required (IU/kg): 25-50
Frequency of Doses: Every other day
Dosing forms and strengths.
Novoeight® is available as a white lyophilized powder in single-use vials.1 Color-coded vial caps offer easy recognition of different dose strengths.
If simple dosing is an important consideration for you and your patients, take a look at Esperoct® [anitihemophilic factor (recombinant), glycopegylated-exei], the extended half-life rFVIII treatment from Novo Nordisk. Routine prophylaxis for patients ≥12 years of age is 50 IU/kg every 4 days—no dose adjustment needed2.
It’s the same 50 IU/kg dose for perioperative dosingb and managing major bleedsc with 40 IU/kg for minor bleeds.
Please click here for Esperoct® Prescribing Information and see Important Safety Information at the bottom of the page.
This regimen may be individually adjusted to less or more frequent dosing2,a
aBased on bleeding episodes.
bFor minor surgeries, additional dose(s) can be administered after 24 hours; for major surgeries, additional doses can be administered every 24 hours in the first week and then every 48 hours in the second week.1
cAdditional dose can be administered every 24 hours for major or life-threatening bleeding.1
Quick reconstitution saves
patients' time.
With MixPro®, it's as quick as attach, twist, and mix.
Designed for safety.
Novoeight® was shown to be safe in clinical studies.3-5
